1986
DOI: 10.1016/0031-6989(86)90028-7
|View full text |Cite
|
Sign up to set email alerts
|

Verapamil, diltiazem and nifedipine inhibit vascular responses to noradrenaline, acetylcholine and 5-hydroxytryptamine in human saphenous vein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…19 –21 However, the reported potency of calcium channel blocker-induced vasodilation in human saphenous veins is in the following decreasing order: verapamil, diltiazem, and nifedipine. 22 This difference in the potency of calcium channel blocker-induced vasodilation may be due to differences in the vessels (rat aorta vs. human saphenous vein) and contractile agonists examined (phenylephrine vs. 5-hydroxytryptamine and acetylcholine). 22…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…19 –21 However, the reported potency of calcium channel blocker-induced vasodilation in human saphenous veins is in the following decreasing order: verapamil, diltiazem, and nifedipine. 22 This difference in the potency of calcium channel blocker-induced vasodilation may be due to differences in the vessels (rat aorta vs. human saphenous vein) and contractile agonists examined (phenylephrine vs. 5-hydroxytryptamine and acetylcholine). 22…”
Section: Discussionmentioning
confidence: 99%
“…22 This difference in the potency of calcium channel blocker-induced vasodilation may be due to differences in the vessels (rat aorta vs. human saphenous vein) and contractile agonists examined (phenylephrine vs. 5-hydroxytryptamine and acetylcholine). 22…”
Section: Discussionmentioning
confidence: 99%